Nurix Therapeutics's total assets for Q4 2025 were $688.13M, an increase of 31.71% from the previous quarter. NRIX total liabilities were $149.39M for the fiscal quarter, a -0.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.